By Dr Simon Ghaly

Book Chapters

Wark G; Samocha-Bonet D; Ghaly S; Danta M, 2023, 'The role of nutrition in inflammatory bowel disease: Disease associations, management of active disease and maintenance of remission', in Encyclopedia of Human Nutrition Volume 1 4 Fourth Edition, pp. 669 - 697, http://dx.doi.org/10.1016/B978-0-12-821848-8.00104-9

Journal articles

Tearle JLE; Sviriaeva E; Zhang F; Jackson KJL; Kaye J; Tavakoli P; Koentgen S; Warren J; Liang RR; Malhotra P; Williams C; Haque A; Arzivian A; Sudhakar KK; Neavin D; Tedla N; Kim A; Haifer C; King HW; Hold GL; Ghaly S; James KR, 2026, 'Primary sclerosing cholangitis displays distinct colonic mucosa topography yet a shared mast cell state with ulcerative colitis', Nature Communications, 17, http://dx.doi.org/10.1038/s41467-026-75231-1

Little RD; Jayawardana TC; Zhang F; Houshyar Y; Koentgen S; Wu N; Ellepola A; Tavakoli P; Read S; Ho A; Chung A; Boussioutas A; Ward MG; Sparrow MP; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg DA; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold GL, 2026, 'Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel Disease', American Journal of Gastroenterology, 121, pp. 1929 - 1943, http://dx.doi.org/10.14309/ajg.0000000000003773

Jairath V; Magro F; Protic M; De Hertogh G; Harpaz N; Hisamatsu T; D’Haens G; Pai R; Yu G; Morris N; Luo WT; Hon E; Escobar R; Biedermann L; Reinisch W; Tron E; Dorado FD; Thin L; Leong R; Seltenreich H; Christensen B; Croft A; Ghaly S; Koch R; Reinisch W; Heeren S; Bossuyt P; Ferrante M; Maximiano FL; Sassaki LY; Baia C; Poli D; de Sousa Carlos A; de Magalhaes Francesconi CF; De Sa Rolim A; Razera J; Neto JS; Rocco R; Stifft J; Soldera J; Silva G; Clemente CM; Di Felice Boratto S; de Campos LT; Borba MR; Rosenfeld G; Ponich T; Lim A; Williams C; Musgrave B; Gauthier S; Liu W; Wang C; Guo H; Chen C; Chen YC; Cao Q; Zhong J; Xu M; Wang Y; Zheng C; Gao X; Chen Y; Miao Y; Wang L; Liu D; Wang B; Song Z; Liu X; Chen B; Jiang Y; Zhan Q; Zhang K; Shen H; Li Z; Wang X; Wang MW; Tian D; Chen L; Tang W; Borzan V; Krznaric Z; Volfova M; Pumprla J; Veberova L; Tichy M; Gregar J; Stepek D; Ulbrych J; Drastich P; Papik Z; Matous J; Lukas M; Koskova R; Fallingborg J; Altwegg R; Fotsing G; Laharie D; Nancey S; Peyrin L, 2026, 'Histologic and combined histologic–endoscopic outcomes with mirikizumab in Crohn’s disease: VIVID-1 trial results', Journal of Crohn S and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjag077

Gilmore R; Pham T; Fernandes RG; Lo S; Wright EK; Rosella O; De Cruz P; Andrew B; Vasudevan A; Gazelakis K; Moore GT; Thin L; Au K; Ghaly S; Chen C; Mohsen W; Goodwin T; Sparrow MP; Ward MG; Chew M; Garg M; Shelton E; Lawrance IC; Thorat A; da Fonseca Pereira C; Begun J; An YK, 2026, 'Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study', Jgh Open, 10, http://dx.doi.org/10.1002/jgh3.70410

Skinner TA; O’Neill RS; Ghaly S; Low JP; Van Laar Veth A; Feller RB, 2026, 'Ileal ulceration and haematochezia in an 83-year old', Frontline Gastroenterology, 17, pp. 182 - 183, http://dx.doi.org/10.1136/flgastro-2025-103067

Giddings HL; Ng KS; Solomon MJ; Arzivian A; Haifer C; Lin H; Pappas C; Clark D; Deacon A; Radford-Smith G; Ebrahimi N; Wu A; Lewis M; Lim R; Zhang J; Vasudevan A; Demase K; Karp J; Fernandes RG; An YK; Ng ZQ; Mackenzie S; Thin L; Greeve T; Moore GT; Connor SJ; Andrews JM; Sparrow MP; Ghaly S, 2026, 'Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn’s Disease in the Biologic Era', Inflammatory Bowel Diseases, 32, pp. 421 - 432, http://dx.doi.org/10.1093/ibd/izaf244

Wu R; Ghali M; Wilson WE; Caquilpan V; Rivas C; Lynch KD; Wark G; Haifer C; Walker G; Radford-Smith G; Begun J; Lawrance IC; Verdon C; Ghaly S; Andrews J; Connor SJ, 2026, 'Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s - 1201, http://dx.doi.org/10.1016/s0016-5085(26)03029-5

Wu R; Ghali M; Wilson WE; Caquilpan V; Rivas C; Lynch KD; Wark G; Haifer C; Walker G; Radford-Smith G; Begun J; Lawrance IC; Verdon C; Ghaly S; Andrews J; Connor SJ, 2026, 'Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s - 1201, http://dx.doi.org/10.1016/s0016-5107(26)02960-3

Ghali M; Wu R; Wilson WE; Caquilpan V; Rivas C; Haifer C; Ng W; Lynch KD; Lawrance IC; Begun J; Walker G; Radford-Smith G; Shahzad A; Boyapati R; Verdon C; Connor SJ; Andrews J; Ghaly S, 2026, 'Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s-1204-s-1205, http://dx.doi.org/10.1016/s0016-5085(26)03036-2

Ghali M; Wu R; Wilson WE; Caquilpan V; Rivas C; Haifer C; Ng W; Lynch KD; Lawrance IC; Begun J; Walker G; Radford-Smith G; Shahzad A; Boyapati R; Verdon C; Connor SJ; Andrews J; Ghaly S, 2026, 'Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s-1204-s-1205, http://dx.doi.org/10.1016/s0016-5107(26)02967-6

Ghali M; Wu R; Wilson WE; Caquilpan V; Rivas C; Kim A; Wark G; Lynch KD; Lawrance IC; An Y-K; Walker G; Radford-Smith G; Shahzad A; Moore G; Verdon C; Connor SJ; Andrews J; Ghaly S, 2026, 'Mo1598 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITHOUT PRIOR ADVANCED THERAPY: CROHN’S COLITIS CARE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s - 1205, http://dx.doi.org/10.1016/s0016-5085(26)03037-4

Ghali M; Wu R; Wilson WE; Caquilpan V; Rivas C; Kim A; Wark G; Lynch KD; Lawrance IC; An Y-K; Walker G; Radford-Smith G; Shahzad A; Moore G; Verdon C; Connor SJ; Andrews J; Ghaly S, 2026, 'Mo1598 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITHOUT PRIOR ADVANCED THERAPY: CROHN’S COLITIS CARE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s - 1205, http://dx.doi.org/10.1016/s0016-5107(26)02968-8

Pudipeddi A; Pajes N; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Fung CL; Redmond D; Chan W; Mourad FH; Kermeen M; Leong RW, 2026, 'Never‐Smoking Is Associated With Histologic Remission in Ulcerative Colitis: A Post‐Hoc Analysis of the VIEWS Randomised Controlled Trial', JCC Plus, 1, http://dx.doi.org/10.1002/jcc5.70051

Wu R; Caquilpan V; Wilson WE; Lynch KD; Ng W; Lawrance IC; Radford-Smith G; Walker G; Begun J; Moore G; Ghaly S; Dutt S; Giles E; Verdon C; Andrews J; Connor SJ, 2026, 'Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s - 992, http://dx.doi.org/10.1016/s0016-5085(26)02588-6

Wu R; Caquilpan V; Wilson WE; Lynch KD; Ng W; Lawrance IC; Radford-Smith G; Walker G; Begun J; Moore G; Ghaly S; Dutt S; Giles E; Verdon C; Andrews J; Connor SJ, 2026, 'Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s - 992, http://dx.doi.org/10.1016/s0016-5107(26)02519-8

Riley M; Wu R; Wilson WE; Caquilpan V; Lynch KD; Ng W; Ghaly S; Gearry R; Schultz M; Lawrance IC; Walker G; Radford-Smith G; Begun J; Shahzad A; Dutt S; Moore G; Verdon C; Andrews J; Connor SJ, 2026, 'Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastroenterology, 170, pp. s-1082-s-1083, http://dx.doi.org/10.1016/s0016-5085(26)02786-1

Riley M; Wu R; Wilson WE; Caquilpan V; Lynch KD; Ng W; Ghaly S; Gearry R; Schultz M; Lawrance IC; Walker G; Radford-Smith G; Begun J; Shahzad A; Dutt S; Moore G; Verdon C; Andrews J; Connor SJ, 2026, 'Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM', Gastrointestinal Endoscopy, 103, pp. s-1082-s-1083, http://dx.doi.org/10.1016/s0016-5107(26)02717-3

An YK; Lindsay N; Allan N; Khoo E; Fernandes R; Gilmore R; Amiss A; Pham H; Ooi SY; Thin L; Lightowler D; Connor SJ; Williams A; De Cruz P; Li Wai Suen CFD; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow MP; White LS; Bryant R; Ding NS; Leong RW; Van Langenberg DR; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2025, 'Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70322

Wu R; Rivas C; Su WK; Deschenes R; Wilson W; Pipicella JL; Connor SJ; Andrews JM; An YK; Begun J; Boyapati R; Dutt S; Gearry RB; Ghaly S; Haifer C; Lawrance IC; Lynch K; Moore G; Radford-Smith G; Shahzad A; Schultz M; Su H; Ng W; Verdon C; Walker G; Wark G, 2025, 'Patterns and Predictors of Steroid Use in a Real-World Inflammatory Bowel Disease Cohort', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70308

Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2025, 'Oral Microbial Diversity is Associated with Biologic Treatment and Metabolic Health Status but not with Disease Activity in Patients with Inflammatory Bowel Disease', Crohn S and Colitis 360, 7, http://dx.doi.org/10.1093/crocol/otaf047

Suo P; Srinivasan A; Thin L; An YK; Fernandes R; Ghaly S; Jeffrey A; Menon S; Olsen N; Skinner T; van Langenberg D; Winston J; Haifer C, 2025, 'Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern', Journal of Gastroenterology and Hepatology Australia, 40, pp. 1174 - 1181, http://dx.doi.org/10.1111/jgh.16916

O’Neill RS; Field A; Kim BSM; Ferguson JS; Ghaly S; Dear RF, 2025, 'Duodenal obstruction secondary to metastatic breast cancer', Journal of Cancer Research and Therapeutics, 21, pp. 755 - 757, http://dx.doi.org/10.4103/jcrt.jcrt_2022_24

Abeyratne K; Harb M; Bensted K; Ghaly S; Connor SJ; Andrews JM; Lynch KD, 2025, 'Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas', Internal Medicine Journal, 55, pp. 461 - 466, http://dx.doi.org/10.1111/imj.16648

Gu B; Su WK; Nano D; Wilson W; Iliescu S; Lynch K; Andrews JM; Connor SJ; Ghaly S, 2025, 'Active perianal fistulising Crohn's Disease is associated with a higher burden of psychological distress, depression, anxiety, stress and opioid use', JOURNAL OF CROHNS & COLITIS, 19, pp. I2311 - I2312, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1455

Su WK; McNamara J; Wilson W; Wark G; Lynch K; Su H; Forbes A; Lawrance I; An YK; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'DOP015 Consistency and Quality of Inflammatory Bowel Disease care in Australasia; Towards Benchmarking, Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i111 - i112, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0054

Davidson C; Su WK; Wilson W; Rivas C; Antoniades S; Wark G; Su H; Ghaly S; Grafton R; Andrews JM; Connor SJ, 2025, 'N26 Factors associated with Inflammatory Bowel Disease (IBD) helpline (HL) utilisation: Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i2481 - i2482, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1558

Koentgen S; Cosier D; Tavakoli P; Leach ST; Dutt S; Ghaly S; Connor SJ; Lemberg DA; Lambert K; Hold GL, 2025, 'P0018 Fat rich dietary habits: Further increasing IBD risk in first degree relatives', Journal of Crohn's and Colitis, 19, pp. i358 - i358, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0192

Tearle J; Zhang F; Jackson K; Malhotra P; Tavakoli P; Koentgen S; Warren J; Williams C; Haque A; Arzivian A; Tedla N; Kim A; King H; Hold G; Ghaly S; James K, 2025, 'P0161 The primary sclerosing cholangitis and ulcerative colitis colonic mucosa defined through paired microbial and single-cell RNA sequencing', Journal of Crohn's and Colitis, 19, pp. i557 - i557, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0335

Koentgen S; Zhang F; Wu N; Jayawardana T; Little R; Tavakoli P; Ghaly S; Connor SJ; Hold GL, 2025, 'P0203 Unique faecal & oral microbiota signatures in first degree relatives of inflammatory bowel disease patients', Journal of Crohn's and Colitis, 19, pp. i607 - i607, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0377

Pudipeddi A; Dhanji P; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i689 - i690, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0431

Su WK; Wilson W; Wark G; Ghaly S; Lynch K; Lawrance I; Walker G; Forbes A; Brett L; An YK; Connor SJ; Andrews JM, 2025, 'P0603 The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealand, Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i1197 - i1198, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0777

Khaing MM; Fernandes RG; An YK; Baraty B; Bryant RV; Ghaly S; Smith RL; Srinivasan A; Hay K; Begun J, 2025, 'P0660 Comparative Accuracy and Reliability of Handheld versus Cart-Based Ultrasound in assessing Inflammatory Bowel Disease Activity', Journal of Crohn's and Colitis, 19, pp. i1290 - i1292, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0834

Pudipeddi A; Lin H; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0754 Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i1453 - i1454, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0928

Cosier D; Lambert K; Karen C; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg D; Houshyar Y; Jayawardana T; Koentgen S; Hold G, 2025, 'P0759 The interplay between dietary intake and disease activity in Australian adults with and without Inflammatory Bowel Disease', Journal of Crohn's and Colitis, 19, pp. i1465 - i1465, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0933

Rivas C; Su WK; Wilson W; Ng W; Ghaly S; Walker G; Forbes A; Su H; Schultz M; Lawrance I; Dutt S; Brett L; Begun J; Lynch K; Andrews JM; Connor S, 2025, 'P1132 Patterns and predictors of steroid use in people with IBD in routine care across ANZ', Journal of Crohn's and Colitis, 19, pp. i2073 - i2073, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1306

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Tavakoli P; Sidhu S; Le A; Boussioutas A; Ward MG; P SM; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Study AIM, 2025, 'P1327 Microbial signatures associated with Inflammatory Bowel Disease in Australia: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2388 - i2389, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1501

Little R; Jayawardana T; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'P1340 Gut microbiota changes are associated with type of advanced therapy in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2410 - i2412, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1514

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward MG; Sparrow MP; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Study AIM, 2025, 'P1344 Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2419 - i2421, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1518

Little R; Jayawardana T; Zhang F; Houshyar Y; Koentgen S; Wu N; Ellepola A; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'P1345 Association of gut microbiota changes and disease activity in patients with Crohn’s disease and ulcerative colitis: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2422 - i2423, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1519

McNamara J; Wilson W; Pipicella JL; Ghaly S; Begun J; Lawrance IC; Gearry R; Andrews JM; Connor SJ, 2025, 'Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort', Gastro Hep Advances, 4, http://dx.doi.org/10.1016/j.gastha.2024.100594

Su WK; McNamara J; Wilson WE; Wark G; Lynch KD; Su HY; Forbes AJ; Lawrance IC; An Y-K; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'Mo1954: CONSISTENCY AND QUALITY OF INFLAMMATORY BOWEL DISEASE CARE IN AUSTRALASIA; TOWARDS BENCHMARKING.', Gastroenterology, 169, pp. s - 1240, http://dx.doi.org/10.1016/s0016-5085(25)03741-2

Jayawardana TC; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong RW; Connor SJ; Hold GL, 2025, 'Mo1960: IMPAIRED HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH ALTERATIONS IN GUT MICROBIOTA SIGNATURES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY.', Gastroenterology, 169, pp. s - 1243, http://dx.doi.org/10.1016/s0016-5085(25)03747-3

Sin HCL; Baraty B; Li V; Ghaly S; Haifer C, 2025, 'Mo2118: INTESTINAL ULTRASOUND IN IMMUNE CHECKPOINT INHIBITORRELATED COLITIS', Gastroenterology, 169, pp. S - 1290, http://dx.doi.org/10.1016/s0016-5085(25)03850-8

Little RD; Jayawardana TC; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold GL, 2025, 'Sa1795: GUT MICROBIOTA CHANGES ARE ASSOCIATED WITH TYPE OF ADVANCED THERAPY IN PATIENTS WITH IBD: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', Gastroenterology, 169, pp. s - 532, http://dx.doi.org/10.1016/s0016-5085(25)02163-8

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1899: EXTENSIVE DISEASE CLEARANCE AS A NOVEL COMPOSITE ENDPOINT TO PREDICT LONG-TERM RELAPSE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. s - 879, http://dx.doi.org/10.1016/s0016-5085(25)02960-9

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1943: CORRELATION OF BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC ENDPOINTS IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. s - 900, http://dx.doi.org/10.1016/s0016-5085(25)03004-5

Khaing MM; Fernandes RG; An Y-K; Baraty B; Bryant RV; Ghaly S; Smith R; Srinivasan A; Hay K; Begun J, 2025, 'Su1947: COMPARATIVE ACCURACY AND RELIABILITY OF HANDHELD VERSUS CART-BASED ULTRASOUND IN ASSESSING INFLAMMATORY BOWEL DISEASE ACTIVITY', Gastroenterology, 169, pp. s - 902, http://dx.doi.org/10.1016/s0016-5085(25)03008-2

Rivas C; Su WK; Wilson WE; Ng W; Ghaly S; Walker G; Forbes AJ; Su H; Schultz M; Lawrance IC; Dutt S; Brett L; Begun J; Lynch KD; Andrews JM; Connor SJ, 2025, 'Tu1094: PATTERNS AND PREDICTORS OF STEROID USE IN PEOPLE WITH IBD IN ROUTINE CARE ACROSS ANZ', Gastroenterology, 169, pp. s-1305-s-1306, http://dx.doi.org/10.1016/s0016-5085(25)03886-7

Cosier D; Lambert K; Charlton K; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg DA; Houshyar Y; Jayawardana T; Koentgen S; Hold GL, 2024, 'Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis †', Nutrients, 16, http://dx.doi.org/10.3390/nu16244349

Back to profile page